Cargando…
Mortality probabilities after revascularization and medical therapy in CAD patients under 60 years old: a meta-analysis study
To estimate death probabilities after coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), and medical therapy (MT) in patients under 60 years old. We conducted a search systematic on PubMed, Embase, Cochrane Library, and Web of Science up to January 2021. The study include...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568744/ https://www.ncbi.nlm.nih.gov/pubmed/34735671 http://dx.doi.org/10.1186/s43044-021-00225-x |
_version_ | 1784594495914901504 |
---|---|
author | Afrouzi, Mohammad Azar, Farbod Ebadi Fard Aboutorabi, Ali Hajahmadi, Marjan Ebadi, Seyed Javad |
author_facet | Afrouzi, Mohammad Azar, Farbod Ebadi Fard Aboutorabi, Ali Hajahmadi, Marjan Ebadi, Seyed Javad |
author_sort | Afrouzi, Mohammad |
collection | PubMed |
description | To estimate death probabilities after coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), and medical therapy (MT) in patients under 60 years old. We conducted a search systematic on PubMed, Embase, Cochrane Library, and Web of Science up to January 2021. The study included three parts. In the probabilities part (A), Comprehensive Meta-Analysis, and in the comparison parts (B and C), Review Manager was used in conducting meta-analyses. Nine studies consisting of 16,410 people with a mean age of 51.2 ± 6 years were included in the meta-analysis. Over a mean follow-up of 3.7 ± 2 years, overall mortality after CABG, PCI and MT was 3.6% (95% CI 0.021–0.061), 4.3% (95% CI 0.023–0.080) and 9.7% (95% CI 0.036–0.235), respectively. The length of follow-up periods was almost the same and did not differ much (p = 0.19). In Part B (without adjustment of baseline characteristics), 495 (4.0%) of 12,198 patients assigned to CABG died compared with 748 (4.5%) of 16,458 patients assigned to PCI (risk ratio [RR]: 0.77, 95% CI 0.50–1.20; p = 0.25). Seventy-four (3.5%) of 2120 patients assigned to CABG and 68 (4.2%) of 1621 patients assigned to PCI died compared with 103 (9.5%) of 1093 patients assigned to MT in equal follow-up periods (CABG-MT: RR 0.34; 95% CI 0.23–0.51; p < 0.002) (PCI-MT: RR 0.40; 95% CI 0.30–0.53; p = 0.02). In Part C, overall mortality after PCI in PACD patients with STEMI was higher in elderly versus young (RR 2.64; 95% CI 2.11–3.30) and is lower in men versus women (RR 0.61; 95% CI 0.44–0.83). Mortality probabilities obtained are one of the most important factors of effectiveness in the economic evaluation studies; these rates can be used to determine the cost-effectiveness of procedures in CAD patients aged < 60 years. |
format | Online Article Text |
id | pubmed-8568744 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-85687442021-11-17 Mortality probabilities after revascularization and medical therapy in CAD patients under 60 years old: a meta-analysis study Afrouzi, Mohammad Azar, Farbod Ebadi Fard Aboutorabi, Ali Hajahmadi, Marjan Ebadi, Seyed Javad Egypt Heart J Review To estimate death probabilities after coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), and medical therapy (MT) in patients under 60 years old. We conducted a search systematic on PubMed, Embase, Cochrane Library, and Web of Science up to January 2021. The study included three parts. In the probabilities part (A), Comprehensive Meta-Analysis, and in the comparison parts (B and C), Review Manager was used in conducting meta-analyses. Nine studies consisting of 16,410 people with a mean age of 51.2 ± 6 years were included in the meta-analysis. Over a mean follow-up of 3.7 ± 2 years, overall mortality after CABG, PCI and MT was 3.6% (95% CI 0.021–0.061), 4.3% (95% CI 0.023–0.080) and 9.7% (95% CI 0.036–0.235), respectively. The length of follow-up periods was almost the same and did not differ much (p = 0.19). In Part B (without adjustment of baseline characteristics), 495 (4.0%) of 12,198 patients assigned to CABG died compared with 748 (4.5%) of 16,458 patients assigned to PCI (risk ratio [RR]: 0.77, 95% CI 0.50–1.20; p = 0.25). Seventy-four (3.5%) of 2120 patients assigned to CABG and 68 (4.2%) of 1621 patients assigned to PCI died compared with 103 (9.5%) of 1093 patients assigned to MT in equal follow-up periods (CABG-MT: RR 0.34; 95% CI 0.23–0.51; p < 0.002) (PCI-MT: RR 0.40; 95% CI 0.30–0.53; p = 0.02). In Part C, overall mortality after PCI in PACD patients with STEMI was higher in elderly versus young (RR 2.64; 95% CI 2.11–3.30) and is lower in men versus women (RR 0.61; 95% CI 0.44–0.83). Mortality probabilities obtained are one of the most important factors of effectiveness in the economic evaluation studies; these rates can be used to determine the cost-effectiveness of procedures in CAD patients aged < 60 years. Springer Berlin Heidelberg 2021-11-04 /pmc/articles/PMC8568744/ /pubmed/34735671 http://dx.doi.org/10.1186/s43044-021-00225-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Afrouzi, Mohammad Azar, Farbod Ebadi Fard Aboutorabi, Ali Hajahmadi, Marjan Ebadi, Seyed Javad Mortality probabilities after revascularization and medical therapy in CAD patients under 60 years old: a meta-analysis study |
title | Mortality probabilities after revascularization and medical therapy in CAD patients under 60 years old: a meta-analysis study |
title_full | Mortality probabilities after revascularization and medical therapy in CAD patients under 60 years old: a meta-analysis study |
title_fullStr | Mortality probabilities after revascularization and medical therapy in CAD patients under 60 years old: a meta-analysis study |
title_full_unstemmed | Mortality probabilities after revascularization and medical therapy in CAD patients under 60 years old: a meta-analysis study |
title_short | Mortality probabilities after revascularization and medical therapy in CAD patients under 60 years old: a meta-analysis study |
title_sort | mortality probabilities after revascularization and medical therapy in cad patients under 60 years old: a meta-analysis study |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568744/ https://www.ncbi.nlm.nih.gov/pubmed/34735671 http://dx.doi.org/10.1186/s43044-021-00225-x |
work_keys_str_mv | AT afrouzimohammad mortalityprobabilitiesafterrevascularizationandmedicaltherapyincadpatientsunder60yearsoldametaanalysisstudy AT azarfarbodebadifard mortalityprobabilitiesafterrevascularizationandmedicaltherapyincadpatientsunder60yearsoldametaanalysisstudy AT aboutorabiali mortalityprobabilitiesafterrevascularizationandmedicaltherapyincadpatientsunder60yearsoldametaanalysisstudy AT hajahmadimarjan mortalityprobabilitiesafterrevascularizationandmedicaltherapyincadpatientsunder60yearsoldametaanalysisstudy AT ebadiseyedjavad mortalityprobabilitiesafterrevascularizationandmedicaltherapyincadpatientsunder60yearsoldametaanalysisstudy |